Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Aesthetic Plastic Surgery
Published in: Aesthetic Plastic Surgery 4/2021

01-08-2021 | Botulinum Toxin | Original Article

Clinical Outcomes Following the Early Application of Multimodal Scar Programs for Facial Incisional Wounds

Authors: Joong Min Suh, Seong Hoon Park, Jun Won Lee, Seong Joo Lee, In Suck Suh, Jong Wook Lee, Hii Sun Jeong

Published in: Aesthetic Plastic Surgery | Issue 4/2021

Login to get access

Abstract

Background

Even though scars are major issues for patients who undergo facial lacerations, programs for their prevention and early management are not well established. The purpose of this study was to evaluate the clinical outcomes of prophylactic scar assessments and early scar interventions in patients with lacerations.

Patients and Methods

A total of 116 patients underwent suture line and scar prevention treatment in the emergency room from 2014 to 2015. In the retrospective study, 46 patients who met all the criteria were included in the study. They were assigned to one of the following two scar prevention programs: the standard scar program for prevention, which included taping, silicone sheets, and ointments, and the multimodality scar program for treatment, which included triamcinolone, botulinum toxins, or CO2 fractional lasers. The patterns of early scar program were investigated for the standard scar prevention program and the multimodality scar management program, and we evaluated the scar assessment scores of the patients at 3 and 6 months.

Results

Scar scores for the patients who received multimodality scar management showed statistically significant improvements in Patient Scar Assessment (PSA) scales, Stony Brook Scar Evaluation Scales (SBSES), Vancouver Scar Scale (VSS) scores, and Visual Analog Scar (VAS) scales (the p values were 0.008, 0.007, 0.017, and 0.01, respectively).

Conclusion

The multimodality scar program is more effective for scar prevention than the standard scar program.

Level of Evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Literature
1.
Fearmonti RM, Bond JE, Erdmann D, Levin LS, Pizzo SV, Levinson H (2011) The modified patient and observer scar assessment scale: a novel approach to defining pathologic and nonpathologic scarring. Plast Reconstr Surg 127:242–247PubMedPubMedCentralCrossRef
2.
Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP (2006) Keloid pathogenesis and treatment. Plast Reconstr Surg 117:286–300PubMedCrossRef
3.
McDonald WS, Deitch EA (1987) Hypertrophic skin grafts in burned patients: a prospective analysis of variables. J Trauma 27:147–150PubMedCrossRef
4.
Singer AJ, Arora B, Dagum A, Valentine S, Hollander JE (2007) Development and validation of a novel scar evaluation scale. Plast Reconstr Surg 120:1892–1897PubMedCrossRef
5.
Louis TA, Lavori PW, Bailar JC 3rd, Polansky M (1984) Crossover and self-controlled designs in clinical research. New Engl J Med. 310:24–31PubMedCrossRef
6.
Burd A, Huang L (2005) Hypertrophic response and keloid diathesis: Two very different forms of scar. Plast Reconstr Surg 116:150e-e157PubMedCrossRef
7.
Bush JA, McGrouther DA, Young VL et al (2011) Recommendations on clinical proof of efficacy for potential scar prevention and reduction therapies. Wound Repair Regen 19(Suppl 1):s32–s37PubMedCrossRef
8.
Mustoe TA, Cooter RD, Gold MH et al (2002) International clinical recommendations on scar management. Plast Reconstr Surg 110:560–571PubMedCrossRef
9.
Gold MH, McGuire M, Mustoe TA et al (2014) Updated international clinical recommendations on scar management: Part 2–algorithms for scar prevention and treatment. Dermatol Surg 40:825–831PubMed
10.
Soltani AM, Francis CS, Motamed A et al (2012) Hypertrophic scarring in cleft lip repair: a comparison of incidence among ethnic groups. Clin Epidemiol. 4:187–191PubMedPubMedCentral
11.
van de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP (2005) Reliable and feasible evaluation of linear scars by the patient and observer scar assessment scale. Plast Reconstr Surg 116:514–22PubMedCrossRef
12.
Baryza MJ, Baryza GA (1995) The Vancouver scar scale: an administration tool and its interrater reliability. J Burn Care Rehabil 16:535–538PubMedCrossRef
13.
Truong PT, Lee JC, Soer B, Gaul CA, Olivotto IA (2007) Reliability and validity testing of the patient and observer scar assessment scale in evaluating linear scars after breast cancer surgery. Plast Reconstr Surg 119:487–494PubMedCrossRef
14.
Vercelli S, Ferriero G, Sartorio F, Cisari C, Bravini E (2015) Clinimetric properties and clinical utility in rehabilitation of postsurgical scar rating scales: a systematic review. Int J Rehabil Res 38:279–286PubMedCrossRef
15.
Lee RH, Gamble WB, Robertson B, Manson PN (1999) The MCFONTZL classification system for soft-tissue injuries to the face. Plast Reconstr Surg 103:1150–1157PubMedCrossRef
16.
Muneuchi G, Suzuki S, Onodera M, Ito O, Hata Y, Igawa HH (2006) Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Recons 40:111–116CrossRef
17.
Makboul M, Makboul R, Abdelhafez AH, Hassan SS, Youssif SM (2014) Evaluation of the effect of fractional CO2 laser on histopathological picture and TGF-β1 expression in hypertrophic scar. J Cosmet Dermatol-US 13:169–179CrossRef
18.
El-Zawahry BM, Sobhi RM, Bassiouny DA, Tabak SA (2015) Ablative CO2 fractional resurfacing in treatment of thermal burn scars: an open-label controlled clinical and histopathological study. J Cosmet Dermatol-US 14:324–331CrossRef
19.
Draaijers LJ, Tempelman FR, Botman YA et al (2004) The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg 113:1960–5PubMedCrossRef
20.
Sullivan T, Smith J, Kermode J, McIver E, Courtemanche DJ (1990) Rating the burn scar. J Burn Care Rehabil 11:256–260PubMedCrossRef
21.
Duncan JA, Bond JS, Mason T et al (2006) Visual analogue scale scoring and ranking: a suitable and sensitive method for assessing scar quality? Plast Reconstr Surg 118:909–918PubMedCrossRef
22.
Shrout PE, Fleiss JL (1979) Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 86:420–428PubMedCrossRef
23.
O'Brien L, Pandit A (2006) Silicone gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev 2006:CD003826
24.
Atkinson JA, McKenna KT, Barnett AG, McGrath DJ, Rudd M (2005) A randomized, controlled trial to determine the efficacy of paper tape in preventing hypertrophic scar formation in surgical incisions that traverse Langer’s skin tension lines. Plast Reconstr Surg 116:1648–56PubMedCrossRef
25.
Kim S, Choi TH, Liu W, Ogawa R, Suh JS, Mustoe TA (2013) Update on scar management: guidelines for treating Asian patients. Plast Reconstr Surg 132:1580–1589PubMedCrossRef
26.
Kim SH, Lee SJ, Lee JW, Jeong HS, Suh IS (2019) Clinical trial to evaluate the efficacy of botulinum toxin type A injection for reducing scars in patients with forehead laceration: a double-blinded, randomized controlled study. Medicine (Baltimore) 98:e16952CrossRef
27.
Jeong HS, Lee BH, Sung HM et al (2015) Effect of botulinum toxin type A on differentiation of fibroblasts derived from scar tissue. Plast Reconstr Surg 136:171e-e178PubMedCrossRef
28.
Hu L, Zou Y, Chang SJ et al (2018) Effects of botulinum toxin on improving facial surgical scars: a prospective, split-scar, double-blind, randomized controlled trial. Plast Reconstr Surg 141:646–650PubMedCrossRef
29.
Capon A, Iarmarcovai G, Gonnelli D, Degardin N, Magalon G, Mordon S (2010) Scar prevention using laser-assisted skin healing (LASH) in plastic surgery. Aesthet Plast Surg 34:438–446CrossRef
30.
Nouri K, Jimenez GP, Harrison-Balestra C, Elgart GW (2003) 585-nm pulsed dye laser in the treatment of surgical scars starting on the suture removal day. Dermatol Surg 29:65–73PubMed
31.
Rosen DJ, Patel MK, Freeman K, Weiss PR (2007) A primary protocol for the management of ear keloids: results of excision combined with intraoperative and postoperative steroid injections. Plast Reconstr Surg 120:1395–1400PubMedCrossRef
32.
Fanous A, Bezdjian A, Caglar D et al (2019) Treatment of keloid scars with botulinum toxin type A versus triamcinolone in an athymic nude mouse model. Plast Reconstr Surg 143:760–767PubMedCrossRef
33.
Phillips TJ, Fung E, Rigby MH et al (2019) The use of botulinum toxin type A in the healing of thyroidectomy wounds: a randomized, prospective, placebo-controlled study. Plast Reconstr Surg 143:375e-e381PubMedCrossRef
34.
Thomas JR, Somenek M (2012) Scar revision review. Arch Facial Plast S 14:162–174CrossRef
35.
36.
Anderson RR, Donelan MB, Hivnor C et al (2014) Laser treatment of traumatic scars with an emphasis on ablative fractional laser resurfacing: consensus report. JAMA Dermatol 150:187–193PubMedCrossRef
37.
Niwa AB, Mello AP, Torezan LA, Osório N (2009) Fractional photothermolysis for the treatment of hypertrophic scars: clinical experience of eight cases. Dermatol Surg 35:773–7PubMedCrossRef
38.
39.
Taniguchi Y, Muraoka M, Harada T, Ito N (2003) Pulsed dye laser treatment for linear scars with concave and erythematous appearance. Aesthet Plast Surg 27:205–208CrossRef
40.
Alster TS, Nanni CA (1998) Pulsed dye laser treatment of hypertrophic burn scars. Plast Reconstr Surg 102:2190–2195PubMedCrossRef
41.
Panchaprateep R, Munavalli G (2015) Low-fluence 585 nm Q-switched Nd:YAG laser: a novel laser treatment for post-acne erythema. Laser Surg Med 47:148–155CrossRef
42.
Bowes LE, Nouri K, Berman B et al (2002) Treatment of pigmented hypertrophic scars with the 585 nm pulsed dye laser and the 532 nm frequency-doubled Nd:YAG laser in the Q-switched and variable pulse modes: a comparative study. Dermatol Surg 28:714–719PubMed
43.
Lee SJ, Lee JW, Kim SH, Suh IS, Jeong HS (2019) Comparison of the scar prevention effect between a carbon dioxide fractional laser and a continuous ablative carbon dioxide laser with a 595-nm Nd:YAG Laser. Aesthet Plast Surg 43:213–220CrossRef
44.
Gassner HG, Sherris DA, Otley CC (2000) Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Plast Reconstr Surg 105:1948–53PubMedCrossRef
45.
Gassner HG, Sherris DA (2003) Chemoimmobilization: improving predictability in the treatment of facial scars. Plast Reconstr Surg 112:1464–1466PubMedCrossRef
46.
Gassner HG, Brissett AE, Otley CC et al (2006) Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study. Mayo Clin Proc 81:1023–1028CrossRefPubMed
47.
Chang CS, Wallace CG, Hsiao YC, Chang CJ, Chen PK (2014) Botulinum toxin to improve results in cleft lip repair. Plast Reconstr Surg 134:511–516PubMedCrossRef
48.
Wang Y, Wang J, Zhang J, Hu C, Zhu F (2019) Effectiveness and safety of botulinum toxin type A injection for scar prevention: a systematic review and meta-analysis. Aesthetic Plast Surg 43:1241–1249PubMedCrossRef
49.
Roh TS, Jung BK, Yun I, Lew DH, Kim YS (2017) Effect of botulinum toxin A on vasoconstriction and sympathetic neurotransmitters in a murine random pattern skin flap model. Wound Repair Regen 25:75–85PubMedCrossRef
50.
Xiao Z, Zhang M, Liu Y, Ren L (2011) Botulinum toxin type a inhibits connective tissue growth factor expression in fibroblasts derived from hypertrophic scar. Aesthetic Plast Surg 35:802–807PubMedCrossRef
51.
Lee SH, Min HJ, Kim YW, Cheon YW (2018) The efficacy and safety of early postoperative botulinum toxin A injection for facial scars. Aesthet Plast Surg 42(2):530–537CrossRef
Metadata
Title
Clinical Outcomes Following the Early Application of Multimodal Scar Programs for Facial Incisional Wounds
Authors
Joong Min Suh
Seong Hoon Park
Jun Won Lee
Seong Joo Lee
In Suck Suh
Jong Wook Lee
Hii Sun Jeong
Publication date
01-08-2021
Publisher
Springer US
Published in
Aesthetic Plastic Surgery / Issue 4/2021
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-021-02330-3

Other articles of this Issue 4/2021

Aesthetic Plastic Surgery 4/2021 Go to the issue

Editor’s Invited Commentary

Invited Response on: “Efficacy and Safety of Lyophilized Articular Cartilage Matrix as an Injectable Facial Filler”

Original Article

Management of Nipple-Areola Deformity

Original Article

Management of Patients Seeking Surgical Rhinoplasty with Previous Nasal Injections of Hyaluronic Acid

Editor’s Invited Commentary

Invited Discussion on: “Experience of Two Different Techniques of Medial Epicanthoplasty with Four-Point Homologous Design—A Cohort Study”

Original Article

Facial Contour Refining after Surgery-First SSRO with Computer-Assisted Design in East Asians

Original Article

Balancing Nipple and Inframammary Fold in Transaxillary Augmentation Mammaplasty with Anatomical Implant: The ‘NIMF’ Classification and Surgical Algorithm